Comments

Leap Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Leap Therapeutics (LPTX) operate in?

Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

LPTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.3431

-0.03-7.07%

After Hours: 7:54 AM EDT

Leap Therapeutics (LPTX) Forecast

News Earnings Leap Therapeutics (LPTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Leap Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:LPTX | Benzinga

Explore Leap Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LPTX.

Open	$0.35
Close	-
Volume / Avg.	105.61K / 2.11M
Day Range	$0.35 - $0.38
52 Wk Range	0.22 - 4.79
Market Cap	$15.30M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	6.25%
Days to Cover	4.9

Recent News

Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer

Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with ongoing business development plans.

Vandana Singh

This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Avi Kapoor

Leap Therapeutics Halts Sirexatamab Combo Therapy For Gastric Cancer ON Unclear Positive Signal, Stock Crashes

Leap Therapeutics' Phase 2 data shows sirexatamab improves ORR in colorectal cancer. Gastric cancer studies end due to lack of PFS benefit.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.35
Close	-
Volume / Avg.	105.61K / 2.11M
Day Range	$0.35 - $0.38
52 Wk Range	0.22 - 4.79
Market Cap	$15.30M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	6.25%
Days to Cover	4.9

About Leap Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Leap Therapeutics (LPTX) stock?

You can purchase shares of Leap Therapeutics (NASDAQ:LPTX) through any online brokerage.

View our list of the best stock brokerages

Who are Leap Therapeutics (LPTX) competitors?

Other companies in Leap Therapeutics’s space includes: Ernexa Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Can Fite Biofarma (AMEX:CANF), Geovax Labs (NASDAQ:GOVX) and GlycoMimetics (NASDAQ:GLYC).

What is the forecast, or price target, for Leap Therapeutics (LPTX) stock?

Leap Therapeutics has a consensus price target of $11.63.

What is the current price for Leap Therapeutics (LPTX)?

The stock price for Leap Therapeutics (NASDAQ: LPTX) is $0.3692 last updated May 23, 2025 at 3:44 PM EDT.

Does Leap Therapeutics (LPTX) pay a dividend?

There are no upcoming dividends for Leap Therapeutics.

When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?

Leap Therapeutics’s Q2 earnings are confirmed for Monday, August 11, 2025.

Is Leap Therapeutics (LPTX) going to split?

There is no upcoming split for Leap Therapeutics.

What sector and industry does Leap Therapeutics (LPTX) operate in?

Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.